11th May 2018 16:43
LONDON (Alliance News) - ValiRx PLC said Friday Nicholas Slater had almost doubled his stake in life science company, which focuses on cancer treatments, to 4.5% after a transaction on Wednesday.
Slater raised his holding to 18.5 million shares, equivalent to a 4.5% stake in the 407.5 million shares. Prior to the transaction, Slater held a 2.7% stake in the company.
Shares in ValiRx closed up 8.4% at 2.79 pence per share on Friday afternoon.
Related Shares:
ValiRx